Related references
Note: Only part of the references are listed.Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Reevaluating the Efficacy and Predictability of Antidepressant Treatments A Symptom Clustering Approach
Adam M. Chekroud et al.
JAMA PSYCHIATRY (2017)
Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study
Christian A. Webb et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method
Frenk P. M. L. Peeters et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Cross-trial prediction of treatment outcome in depression: a machine learning approach
Adam Mourad Chekroud et al.
LANCET PSYCHIATRY (2016)
Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study
Tsafrir Greenberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Identifying Predictors, Moderators, and Mediators of Antidepressant Response in Major Depressive Disorder: Neuroimaging Approaches
Mary L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Accounting for Dynamic Fluctuations across Time when Examining fMRI Test-Retest Reliability: Analysis of a Reward Paradigm in the EMBARC Study
Henry W. Chase et al.
PLOS ONE (2015)
Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo
Seetal Dodd et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain Criteria (RDoC)
Soren D. Ostergaard et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
A Clinical Risk Stratification Tool for Predicting Treatment Resistance in Major Depressive Disorder
Roy H. Perlis
BIOLOGICAL PSYCHIATRY (2013)
Comparing HAMD17 and HAMD subscales on their ability to differentiate active treatment from placebo in randomized controlled trials
Ruud Boessen et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Correlated variables in regression: Clustering and sparse estimation
Peter Buehlmann et al.
JOURNAL OF STATISTICAL PLANNING AND INFERENCE (2013)
Personality Traits as Risk Factors for Treatment-Resistant Depression
Michio Takahashi et al.
PLOS ONE (2013)
Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression
Michio Takahashi et al.
PLOS ONE (2013)
The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction
Sidney H. Kennedy et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Staging methods for treatment resistant depression. A systematic review
Henricus G. Ruhe et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets
P. Bech et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Risk factors of treatment resistance in major depression: Association with bipolarity
Dominika Dudek et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Recursive Subsetting to Identify Patients in the STAR*D: A Method to Enhance the Accuracy of Early Prediction of Treatment Outcome and to Inform Personalized Care
Anthony Y. C. Kuk et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy
Gijs Santen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials
Marcelo T. Berlim et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation
Mark Hyman Rapaport et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale
RS McIntyre et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Dimension reduction-based penalized logistic regression for cancer classification using microarray data
L Shen et al.
IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2005)
A closer look at treatment resistant depression: is it due to a bipolar diathesis?
V Sharma et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Regularization and variable selection via the elastic net
H Zou et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2005)
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
AJ Rush et al.
CONTROLLED CLINICAL TRIALS (2004)
Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study
M Fava et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2003)
Share Paper
